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Abstract In mammalian cells, the Bcl-2 and Bcl-x(L) proteins 
suppress programmed cell death whereas the topographically sim- 
ilar Bax protein accelerates the apoptotic process. Recently pub- 
lished data suggest hat expression of the human Bax-a gene is 
lethal for the yeast Saccharomyces cerevisiae and that this toxic- 
ity can be overcome by co-expressing Bcl-2 or Bcl-x(L). Our 
findings corroborate these results. However, we find that al- 
though Bax induction invariably stops cell growth under all cir- 
cumstances, it does not lead to death in 'petite' cells. Petites 
cannot respire because they lack functional mitochondria. It 
seems that in 'grande' cells, which do possess normal mitochon- 
drial DNA, nutritional imitation is critical for increased mortal- 
ity. Surprisingly, murine Bcl-2 lacking the membrane anchor of 
human Bcl-2 has no effect on grande cells, but can efficiently 
rescue petites in rich medium. It has been suggested that the 
C-terminal membrane anchor of human Bcl-2 may have a crucial 
role in rescuing apoptosis in mammalian cells. When murine Bcl-2 
is fused to the membrane anchor of yeast mitochondrial Mas70 
protein, the Bcl-2 variant mBci-2-mma rescues not only petites 
but also grandes, just like human Bcl-x(L). The rescuing ability 
of Bcl-x(L), which contains its own membrane anchor, surpasses 
that of mBcl-2-mma. Our results indicate that the process involv- 
ing Bax-induced growth inhibition followed by possible lethality, 
and the rescuing effect of Bcl-2 or Bci-x(L) is linked to yeast 
mitochondrial function. We propose a model which is consistent 
with these observations. 
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I. Introduction 
Programmed cell death (PCD) in multicellular organisms i
essential in development and can act as a final safety mecha- 
nism to eradicate "sick' cells (i.e. cancer cells or infected cells) 
[1-4]. In mammals, the onset of PCD is characterized bya series 
of morphological changes in the affected cell. These changes are 
referred to as apoptosis and include membrane blebbing, auto- 
phagocytosis and selective DNA fragmentation at the junctions 
of nucleosomes [1]. 
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Abbreviations: Bax, protein encoded by human Bax-et gene; Bcl-x(L), 
human Bcl-x(L) protein; Bi, yeast strain with integrated copy of 
GALlOp Bax expression cassette; CYPlp, promoter from yeast cy- 
tosolic cyclophilin gene; GALlOp, promoter from yeast GALIO gene; 
Gal, galactose; GA PDHp, promoter f om yeast glyceraldehyde-3-phos- 
phate dehydrogenase gene; Glu, glucose; hBcl-2, human Bcl-2 protein; 
hma, human Bcl-2 membrane anchor; mBcl-2, murine Bcl-2 protein; 
mma~ yeast Mas70 protein membrane anchor; PCR, polymerase chain 
reaction; PCD, programmed cell death. 
The Bcl-2 protein counters a variety of stimuli which induce 
apoptosis [1,2]. Bcl-2 has turned out to be the founding member 
of a family of proteins. Some of the proteins of this family also 
contain a stretch of hydrophobic amino acids in their C-termi- 
nus that allows for post-translational insertion into intracellu- 
lar membranes of the mitochondrion, the nucleus and the endo- 
plasmic reticulum [5,6]. It has been shown that the C-terminal 
tail is important for Bcl-2's cell death blocking activity in mam- 
malian cells [5-7]. 
The Bcl-2 family [4, 8-13] includes Bax, a homologous pro- 
tein that dimerizes with Bcl-2 and when overproduced pro- 
motes apoptosis [4]. Bax also interacts with Bcl-x(L) which is 
known to suppress cell death [4,8]. 
Recently, it was reported that Bax induces growth arrest in 
the yeast Saccharomyces cerevisiae [14,15]. Quite surprisingly, 
this arrest is rescued by Bcl-2, Bcl-x(L) and Mcl-1 proteins, 
suggesting that important components ofthe apoptotic process 
may be conserved from a simple unicellular eukaryote (i.e. 
yeast) to complex multicellular organisms [14]. Furthermore, 
deletion analysis of human Bcl-2 has defined certain structural 
domains which can compensate for the growth inhibitory ef- 
fects of Bax in yeast [15]. The inferences made on growth arrest 
and rescue have been based solely on co-transformation fre- 
quencies of plasmids carrying ene fusions of 'Bcl-2' (i.e. full- 
length Bcl-2, deletion mutants of Bcl-2 or a Bcl-2 family mem- 
ber) and a plasmid carrying aBax fusion. Since a plasmid which 
constitutively expresses the Bax fusion does not furnish any 
transformants, Bax was deduced to be 'lethal' for yeast [14,15]. 
The Bax/'Bcl-2' constructs, which were used to obtain these 
observations, were all fused to a nuclear targeting signal and 
domains from the yeast transcription activator Gal4 (com- 
monly used in the yeast wo-hybrid system) [14,15,16]. Fusion 
proteins, bearing a Bcl-2-1ike protein, were classified as 'rescu- 
ing' from the 'lethal' effect of Bax when transformants were 
obtained in cells coexpressing the Bax fusion [14,15]. 
In order to investigate the effects of Bax and its rescuing 
partners, Bcl-2 and Bcl-x(L) on S. cerevisiae in more detail, we 
have attempted to express the proteins not as two-hybrid fu- 
sions but as discrete ntities. The proteins have been expressed 
in yeast, without any signal peptide, under the control of the 
inducible GALI/GALIO promoter. Beyond the confirmation of
earlier observations [14,15], we find that in yeast cells Bax- 
mediated cell death (as observed microscopically through loss 
of cell membrane integrity) and growth inhibition are probably 
two distinct events. We clearly demonstrate that the functional 
mitochondrion (the organelle which allows respiration) in Bax- 
containing cells does not play any part in impeding cell growth. 
However, the presence of mitochondrial DNA is essential for 
cell death. We also observe that the C-terminal membrane 
anchor domain of Bcl-2 plays a definitive role in the rescue of 
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respiration-competent Bax expressing cells (i.e. cells which con- 
tain intact mitochondrial DNA),  while it is seemingly redun- 
dant in cells with dysfunctional mitochondria. Our results, ob- 
tained from yeast, imply that the oxidoreductive environment 
of the mitochondrion could be an important element in both 
apoptosis and its inhibition as seen in mammalian cells. 
2. Materials and methods 
2.1. Bax expression cassette and expression plasmids 
The gene coding for the human Bax protein [17] was chemically 
synthesized using yeast codon bias. The gene was assembled from 
complementary deoxyoligonucleotides, each 70 to 80 base long and 
having 20 bp overlaps, via (i) 5' to 3' chain extension followed by 
(ii) polymerase chain reaction (PCR) amplification. All PCRs have been 
performed using the Vent polymerase (Biolabs). The complete Bax gene 
(a BglII-XbaI fragment) was constructed in three parts. Each segment 
was first subcloned in pUCI9 and the authenticity of the clones were 
confirmed by DNA sequencing. A SalI-BamHI GALIO promoter f ag- 
ment [18], the BglII-XbaI Bax gene sequence and a XbaI-SacI fragment 
containing the SUC2 transcription terminator (with or without the 
5' DNA sequence coding for the c-myc epitope EQKLISEEDLNG) 
were subcloned in the 2/l-vector pDP34 (a S. cerevisiae Escherichia coli 
shuttle vector) [19]. The episomal plasmid pWG1 was thus obtained. 
The entire Bax expression cassette was amplified by PCR from pWGI 
as a BgIII-XhoI fragment. This expression cassette was then subcloned 
between the BamHI and XhoI sites of a yeast integrating vector pPFY7 
(a YIp vector with LEU2 as yeast selection marker) [20], or between 
the BamHI and SalI sites of pDP34 (a YEp vector containing the 
complete 2¢t sequence and with URA3 and dLEU2 as yeast selection 
marker) and pDP83 (a CEN-14 YCp vector with URA3 as yeast selec- 
tion marker) [19,20]. The plasmids pWG2 (YIp), pWG3 (YEp) and 
pWG4 (YCp) were thus obtained. 
To eliminate the possibility of the c-myc tag having an effect on yeast 
cell growth, Bax expression plasmids (similar to pWG2, pWG3 and 
pWG4) without a c-myc tag have been constructed. 
Plasmids containing expression cassettes, driven by the constitutive 
promoters GAPDHp (from the yeast glyceraldehyde-3-phosphate dehy-
drogenase gene) and CYPlp (from the yeast cytosolic yclophilin gene) 
[19,21], were also constructed. These two expression plasmids are re- 
ferred to as pDP34/GAPDHp Bax and pDP34/CYPlp Bax, respec- 
tively. 
2.2. Human BcLx(L) expression cassette 
The complete coding region of the human Bcl-x(L) protein [22] was 
cloned from a thymus cDNA library (Clontech) as a BglII-XbaI frag- 
ment by PCR. DNA sequencing confirmed the authenticity of the 
isolated sequence. The Bcl-x(L) expression cassette, under the control 
of the GALlOp and CYPlp, was subcloned in pDP34 as described in 
section 2.1 and is referred to as pDP34/GALlOp-Bcl-x(L) and pDP34/ 
CYPlp-Bcl-x(L), respectively. 
2.3. Expression cassettes for murine Bcl-2 and murine Bcl-2 variants 
The murine Bcl-2 clone [23] was obtained from Professor S. J. Kors- 
meyer (Washington University, St. Louis). A BglII-XbaI fragment was 
isolated by PCR in such a way that the 3'-end of the gene coded for the 
peptide TWIQDNGGWDAFVE. This modified murine Bcl-2 sequence 
(referred to in this study as mBcl-2) lacks the region which corresponds 
to the membrane anchor of human Bcl-2 (hBcl-2) [24] but contains the 
complete BH2 domain as present in hBcl-2. The gene mBcl-2 was 
subcloned in pUC 19 to yield pUC 19/mBcl-2. The mBcl-2 yeast expres- 
sion cassette (under the control of GALlOp and CYPlp) was subcloned 
in pDP34, in a manner identical to the cloning of Bax and Bcl-x(L) 
expression cassettes ( ee sections 2.2 and 2.3). 
The plasmid pUC19/mBcl-2 was digested with XbaI and double- 
stranded linkers (5'-ends of linkers contain XbaI overhangs, one of 
which recreates an XbaI site after ligation), coding for the membrane 
anchor egions of hBcl-2 (KTLLSLALVGACITLGAYLGHK; hma) 
[5,7] and the yeast mitochondrial outer membrane protein Mas70 
(KTAILATVAATGTAIGAYYYYNQ; mma) [7], were ligated unidi- 
rectionally. The two new plasmids bear (i) a C-terminal fusion of mBcl- 
2 and hma and (ii) a C-terminal fusion of mBcl-2 and mma. The 
expression cassettes containing BgllI-XbaI fragments of mBcl-2-hma 
and mBcl-2-mma (under the control of GALlOp and CYPlp) were later 
subcloned in pDP34 as described above. 
2.4. Strains and media 
Most of the experiments reported here were performed using the 
strain HT444 (MATa leu2-3 leu2-112 his4-519 ura3 lys2). However, 
the basic data relating to growth arrest and cell mortality were 
all confirmed in 3 other strains: SE312 (MATer leu2 lys2 his4 ura3 
pral prbl), TFY2 (MATot his ura3-52 trpl-285 ace1 
LEU2:: YIpCL: CUP1 r GaF) [19] and W3116 (MATa leu2-3 leu2-112 
his3 PCRIA:: HIS3 ura3-52 lys2 pep4A1137) [20]. An integrated copy 
of pWG2 in the LEU2 locus of HT444 (HT444 :: pWG2) is referred to 
as Bi (i.e. the Bax integrant). 
The yeast cell culture media have been described earlier [25]. The 
minimal medium is denoted as SD (0.67% yeast nitrogen base, without 
any amino acids; Difco) whereas rich medium is referred to as YEP (2% 
bacto-peptone, 1% yeast extract; both from Difco). The supplements 
added to the SD medium were those required for growth of the specific 
strain. The carbon sources which have been used for growth are 2% 
(w/v) glucose (Glu; Fluka) or 2% (w/v) sodium lactate (Lactate; Sigma) 
or 2% (w/v) galactose (Gal; Fluka). 
2.5. Petite formation 
Petite mutations were induced in strain Bi (the Bax integrant; see 
above) using ethidium bromide as described by Sherman et al. [25]. A 
loopful of cells were grown in the dark at 30°C for 36 h, in 10 ml of 
SD-Glu medium which contained 10¢tg/ml ethidium bromide. The cells 
were spread on YEP-GIu plates to give single colonies. The colonies 
were replica plated on to YEP plates containing 3% glycerol. Those 
colonies which grew only on YEP-Glu plates, but not on YEP-glycerol, 
were classified as petites. The basic observation that petites are growth 
inhibited but not killed by galactose induction of Bax was confirmed 
with 3 separate petite segregants. In order to find if mBcl-2 rescued 
petites, the grande strain Bi :: pDP34/GAL10p-mBcl-2 was converted to 
petites as above. Simultaneous growth of 5 individual petite colonies 
confirmed galactose resistance. Similar observations were made on Bi 
petites transformed with pDP34/GAL10p-mBcl-2. 
2.6. Cell staining 
Two stains (methylene blue and erythrosine B) were used for identi- 
fying cell death (i.e. cells which have lost membrane integrity). The cells 
were initially grown in SD-Glu (in which case the cells were washed 
3 times in sterile water before induction with galactose) or in SD-lactate 
(in which case the cells were directly induced with galactose). 
In order to stain with methylene blue, cells were first resuspended in 
an appropriate volume of 0.9 M KC1 and were then treated with the 
dye solution at a final concentration f 0.5 g/1 [26]. 
The medium used for staining with erythrosine B [27] contained 
agarose (2% w/v) in SD, an appropriate carbon source and 7.5 ¢tM 
erythrosine B (Serva). Cells were first spread on microscope slides and 
then incubated at 30°C in a humidifying chamber. 
Methylene blue stained cells were counted using a haemocytometer. 
Fig. 1. Erythrosine B and methylene blue staining. In panels (A) and (B) the same cells are visualized after 5 h and 23/24 h. In panel (A), HT444 
transformed with pDP34 is shown. Cells divide normally when grown in minimal SD-Gal medium. The photographs are shown in high magnification 
(400×). Panel (B) shows HT444 transformed with pDP34/GallOp-Bax (see Section 2) when grown in SD-Gal. Cells have been photographed under 
the same magnification asin panel (A). Some rare cell division is seen after ~5 h. The cells, that do not divide, die soon after this time (pink stained 
cells). Note the dramatic differences in cell division between the 23/24 h time points of panels (A) and (B). Panel (C) shows (same magnification as 
above) the fate of a large number of cells (HT444::pDP34/GallOp-Bax), after 12 h of induction, upon methylene blue staining (-90% cells are stained 
blue). 
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(A) No Bax expression : Erythrosine B staining 
Time = 5 hours Time = 23 hours 
(B) Bax expression : Erythrosine B staining 
Time = 5 hours Time = 24 hours 
(C) Bax expression : Methylene blue staining 
t i 
0 - -  ~ • a Oe'~ 0 
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The average and standard error of mean (S.E.M.) was calculated sepa- 
rately for blue (dead) and white ('live') cells in each quadra. The per- 
centage of blue cells were then defined as lying between the extremes 
(e.g. the highest value would be (Blue+S.E.M.b~J (Blue+ 
S.E.M.blu<. + White - S.E.M.,,ki,o ). The experiments were repeated and 
the final range was defined as the overlap of results from different 
experiments. 
2.7. Spot tests 
Cells were suspended in water and 5/tl aliquots were spotted on 
appropriate minimal medium or rich medium plates. 
3. Results and discussion 
The human Bax protein [17] has been expressed in yeast, 
using the inducible GALIO promoter, under a variety ot" condi- 
tions. The effect of inducing Bax in grande (Rho +) and petite 
(rho-) yeast cells, employing different forms of preculture and 
induction media, is summarized in Table 1. The data were 
compared with those of the control strain HT444:: pPFY7. For 
this strain, no cell mortality was observed in liquid medium 
even after prolonged growth in galactose (Gal), lactate or glu- 
cose (Glu). It should be noted that pDP34/GAPDHp Bax and 
pDP34/CYPlp-Bax (plasmids which contain Bax expression 
cassettes under the control of two constitutive promoters 
GAPDH and CYP1; see section 2), when transformed into 
various yeast strains, yielded no transformants. 
Our results show that a low level induction of Bax is suffi- 
cient to suppress growth and cause some mortality. This is 
indicated (a) by the accumulation of dead ceils in stationary 
phase even in the absence of galactose (Table 1: row 6, column 
d), (b) from the levels of mortality in lactate (row 4, column d) 
and (c) from the growth inhibition observed on resuspension 
of cells in lactate medium (row 4, column f). It is significant 
that, although the petites (Bi rho-) do not grow at all in rich 
or minimal galactose media (see rows 1, 2 and 3, column e). no 
cell mortality is seen even after prolonged incubation (see rows 
1, 2 and 3, column c). It is also interesting to note that Bax- 
expressing randes divide slowly for 5 h in rich YEP-Gal me- 
dium (row 1, column f). However, this does not prevent cell 
mortality which follows immediately afterwards (row 1, column 
d). In minimal SD-Gal medium, the grandes fail to show any 
cell division (row 2, column f) which is in contrast o growth 
in rich medium. Moreover, there is increased mortality (com- 
pare rows 1 and 2, column d). It is clear that, in rich YEP-Gal 
medimn, grande yeast shows less growth inhibition and mortal- 
ity than in minimal SD medium (compare rows 1 and 2, column 
d). This is also reflected in the observation that cells, initially 
grown in YEP-GIu instead of SD-Glu, manifested perceptibly 
decreased cell growth inhibition and cell death even if cells were 
later transferred to Bax-inducing minimal SD-Gal medium 
(Table 1, compare rows 3 and 2, column d). 
It has been suggested on the basis of co-transformation ex- 
periments that Bax causes cell death, rather than simple growth 
inhibition [14,15]. In a broad sense, this conclusion is supported 
by our observations with grande yeast Bi (Table 1, column d). 
However, we see no cell mortality (as measured by loss of 
membrane integrity) with the petite yeast Bi rho (Table I, 
column c). We observe a definite delay between the time when 
cell division is halted (just after induction of Bax) and the onset 
of membrane breakdown. This is apparent when plated cells, 
obtained after induction in SD-Gal minimal medium, are exam- 
ined under the microscope and stained with erythrosine B (Fig. 
1; panel B). Although cell growth arrest occurs immediately 
alter Bax induction (i.e. t > 0 h), cell death is observed only 
after 5 h. It seems as if cells which divide are more liable to 
survive (Fig. 1, panel B, 24 h). However, the majority of cells 
lose membrane integrity after 12 h (Fig. 1, panel C). In marked 
contrast o this, control cultures of HT444 grow normally (viz. 
Fig. 1, panel A, 5 and 23 h). 
The marine Bcl-2 protein [23] differs from human Bcl-2 
(h Bcl-2) [24] most significantly at the C-terminus. It is suspected 
that the C-terminal membrane-spanning signal anchor se- 
quence of hBcl-2, which is missing from the marine protein, has 
an important function in preventing apoptosis [5-7]. The gene 
encoding the published murine Bcl-2 sequence [23] was ex- 
tended at the 3'-end to incorporate the peptide 
TWIQDNGGWDAFVE so that the BH2 domain [4,8], as 
Table 1 
Inhibition of cell growth and cell death (as monitored by methylene bhle staining), after induction of Bax in yeast 
Preculture Induction Methylene blue staining Growth in Bax-inducing 
medium medium after 24 h (%) medium 
Petite Grande Petite Grande 
1 YEP-GIu YEP-Gal 0* 22 35 No growth Growth ['or 2 to 5 h ~' 
2 YEP-GIu SD-Gal 0* 50 70 No growth No growth 
3 SD-GIu SD-Gal 0* 80 90 v No growth No growth 
4 SD-GIu SD-lactate ND 5 10 ND Slow Growth ~ 
5 SD-Lactate SD-Gal ND 80 90 v ND No growth 
6 YEP-GIu To stationary phase 0* 5 10 
a b c d e f 
The strain Bi (HT444 :: pWG2) was grown in liquid medium using a combination of different pre- and main-cultures (see section 2). The media SD-GIu, 
SD-Gal, YEP-GIu and YEP-Gal have been described in section 2 and, where necessary, were supplemented with the appropriate amino acids and 
uracil. Although the effects described here pertain to single-copy expression of Bax, no significant differences were observed on expressing the protein 
from the multicopy episomal plasmid pDP34. 
*For the petite, no methylene blue stained cells were seen after 24 h. The number of cells which were examined varied but in all cases exceeded I000. 
~'The growth rate of Bi in YEP-Gal was similar to the control HT444:: pPFY7 over the first few hours (this was followed by comparison of bud 
appearance in Bi and HT444::pPFY7). In contrast, for strain Bi the growth rate fell from a value of#----0.4 h -~ (in SD-Glu) to <0.05 h i 
(in SD-Lactate) while for the control strain it decreased from 0.4 h ' to 0,15 h ~. The measured growth rates were maintained for at least a 24 h 
period. 
VMethylene blue staining indicates loss of membrane intcgrity. The liict that a cell remains unstained oes not indicate that the cell would be able 
to divide again when Bax expression is repressed. In our experiments, a small percentage of cells (less than 1%) do grow when transferred back to 
glucose medium, even though 80 to 90% of cells were initially stained. 
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found in hBcl-2, was complete [24]. This modified gene is re- 
ferred to as mBcl-2. The mBcl-2 gene has been further extended 
at the Y-end to incorporate signal anchor regions from hBcl-2 
[5,7] and the yeast outer mitochondrial membrane protein Mas 
70 [7]. We have co-expressed the three proteins mBcl-2, mBcl- 
2-hma (hma being the hBcl-2 membrane anchor) and mBcl-2- 
mma (mma being the Mas70p membrane anchor) with Bax, in 
order to find out if the membrane anchor sequence has any 
influence on the survival of yeast cells. 
Table 2 summarizes the effects of co-expressing Bax with 
Bcl-2-1ike proteins (from many experiments), under the control 
of the inducible GALIO promoter. Fig. 2 depicts some of these 
effects more clearly. Expression of human Bcl-x(L) protein in 
Bi (Rho +) rescues Bax poisoned grande cells in both rich and 
minimal media (Table 2, row 1) but murine Bcl-2 does not 
(Table 2; row 4). Surprisingly however, mBcl-2 strongly rescues 
the petite yeast Bi rho- in rich medium but only marginally in 
SD medium (Table 2; row 5). Although mBcl-2 (without a 
membrane anchor domain) is incapable of diluting the toxic 
effects of Bax in grande cells (Table 2; row 4), both mBcl-2-hma 
and mBcl-2-mma proteins can negate Bax to varying degrees 
(compare rows 6 and 9). It seems that the membrane anchor 
from the Mas70 protein is more effective in restoring growth 
in grande cells than the similar domain from hBcl-2. However, 
full-length Bcl-x(L) seems to be even more potent in its rescuing 
capacity than mBcl-2-mma. The undoubted superiority of Bcl- 
x(L) in rescuing Bax-induced grande cells is emphasized by the 
growth of Bi in the presence of poorly expressed Bcl-x(L) (from 
the weakly constitutive promoter CYPlp ;  compare rows 1, 3 
with 6, 8 and 9, 10) [21]. However in this context, it is notewor- 
thy that Bcl-x(L) and mBcl-2 mma (two proteins with mem- 
brane anchors) are quite alike mBcl-2 (a protein without a 
membrane anchor) in their capacity to rescue Bi rho- petites in 
Table 2 
Rescue of yeast cells from Bax-mediated growth-inhibition r cell death 
by Bcl-x(L), mBcl-2, mBcl-2-hma nd mBcl-2-mma proteins 
Expression cassettes Strain YEP-Gal SD-Gal 
1 GALIOp-Bcl-x(L) Bi +++ +++ 
2 GALIOp-Bcl-x(L) Bi rho- ++ - 
3 CYPIp Bel-x(L) Bi +++ +++ 
4 GALIOp-mBel-2 Bi - 
5 GALlOp-mBcl-2 Bi rho ++ +/- 
6 GALlOp-mBcl-2-mma Bi ++ - 
7 GALlOp-mBcl-2-mma Bi rho ++ - 
8 C YPlprnBcl2-mma Bi - - 
9 GALlOp- mBel-2-hma Bi +/- - 
10 C YPlp-mBcl-2-hma Bi - - 
11 - Bi - - 
12 - Bi rho - 
The proteins are expressed under the control of GALlOp or CYPlp 
from the episomal plasmid pDP34, in yeast strains Bi (the Bax inte- 
grant) and the petite Bi rho-. Rows 11 and 12 show the results for 
transformants of pDP34, which contain no expression cassette. Cell 
suspensions were spotted on to YEP-Gal and SD-Gal plates or onto 
control plates (YEP-GIu and SD-Glu). ' - '  denotes the complete ab- 
sence of growth on test plates while confluent growth was observed on 
control plates. '+++' indicates that there is nearly identical growth on 
test plates and control plates. '++' implies that there is rescue but less 
growth on test plates than on controls. Still weaker growth on test 
plates is depicted as '+', whereas '+/- '  denotes growth of point colonies. 
Fig. 2 visualizes ome of the data summarized in this table. It should 
be noted that the control strain HT444 rho- grows well both in SD-Glu 
and SD-Gal. 
YEP-Glu YEP-Gal 
YEP-Glu YEP-Gal ! 
Bi: :Bci-x(L) 
Bi: :  - 
Bi :  :mBcl-2 
Bi: :mBc i -2 -hma 
Bi: :mBc l -2 -mma 
YEP-Glu YEP-Gal SD-Gal 
Bi ( rho-) : :  - 
B i  (rho-)::Bcl-x(L) 
Bi ( rho- )  ::mBcl-2 
Bi (Rho+): :mBci-2 
Bi (Rho  +): :Bcl-x(L) 
Fig. 2. Induction of Bax expression i  the strain Bi (Bax integrant), in 
the presence of Bcl-2-1ike proteins. Bi was transformed with different 
episomal plasmids (pDP34-derived) which contained expression cas- 
settes for specific Bcl-2-1ike genes (as indicated). All gene expressions 
are under the control of the GALIO promoter. ' ' denotes the transfor- 
mants of pDP34 (which contain o expression cassette). Equal number 
of cells were spotted on minimal SD and rich YEP medium plates, in 
the presence of glucose (Glu) or galactose (Gal), as described in section 
2. The control strain HT444 rho grows well both in SD-Glu and 
SD-Gal (data not shown). 
rich medium (compare rows 2 and 7 with row 5). However, 
petites in minimal medium are unaffected and remain growth 
arrested in the presence of Bcl-x(L) and mBcl-2 mma. 
The overall significance of our results has been highlighted 
in the data depicted in Tables 1 and 2. Primarily, we find that 
Bax causes inhibition of cell growth and this can lead to cell 
death under certain conditions. We show that cell death is 
subtly dependent on the type of media which is used for growth, 
before and after Bax induction (Table 1, rows 1-3). The fact 
that the petite Bi rho- yeast does not suffer lethality in the 
presence of Bax but is still growth inhibited, suggests that cell 
death is probably mitochondria-dependent. A lethal mitochon- 
dria-dependent pathway could be completely separate from a 
non-lethal mitochondria-independent growth arrest, or they 
could be overlapping events. The fact that growth inhibition 
precedes large scale cell death by at least 5 h indicates that cell 
death (which is mitochondria-dependent) canbe subsequent to 
the mitochondria-independent pathway (Fig. 3). 
It has been shown that a truncated version of hBcl-2 (1-196) 
does not suppress Bax-mediated growth inhibition in yeast [15]. 
The mBcl-2 molecule is analogous to hBcl-2 (1-196) and is also 
ineffective against overcoming Bax's toxicity in grande yeast. 
However, the mBcl-2 protein rescues petites quite proficiently. 
Our data also indicate that mBcl-2 can compensate for Bax in 
grande cells if it is C-terminally linked to the membrane span- 
ning region of the yeast Mas70p. We conclude that the capacity 
of Bcl-2 to rescue grande cells from the effects of Bax relies on 
a C-terminal membrane anchor. 
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Fig. 3. Possible pathways for Bax action. Bax is induced in dividing cells 
and causes ceils to enter dormant states S 1 (mitochondria-independent) 
and $2 (mitochondria-dependent). Petite cells can go through the SI 
pathway only. But grande cells have a choice between SI and $2 and 
the two states are probably in equilibrium. In minimal SD medium, the 
equilibrium shifts towards $2 whereas in rich YEP medium S1 is pre- 
ferred (as explained in Section 3). However, cell death requires the $2 
state. The C-terminal membrane anchor in Bcl-2-1ike proteins (as in 
Bcl-x(L) and in mBcl-2-mma) is essential for rescue from $2, while it 
appears to be redundant in S1 (as in the case of mBcl-2). 
Yeast can divide and grow using a respiratory pathway 
which is dependent on mitochondrial function. Unlike mam- 
malian cells which do not survive in the absence of mitochon- 
dria, yeast has a viable alternative. Petite yeast cells can grow 
merely through fermentation. In cells expressing Bax, growth 
arrest occurs independent of the mitochondria via an S1 state, 
as seen in petites (Fig. 3). In grande cells which possess func- 
tional mitochondria, growth arrest at S1 could progress to cell 
death via a respiration dependent $2 state (Fig. 3). Of course, 
cell death would be facilitated in medium which would encottr- 
age greater espiration. Rapidly growing cells encounter a res- 
piratory bottle neck (viz. in YEP medium) [28,29]. Minimal SD 
medium, which allows only slow cell growth would thus permit 
more respiration than YEP medium. In this respect it is worth 
observing that galactose is a less efficient inhibitor of respira- 
tion than glucose [30]. Our observations confirm that cell death 
is indeed more profound under conditions where cells can re- 
spire better (viz. in SD medium rather than in YEP medium; 
Table 1; rows 1-3). 
The three proteins mBcl-2, mBcl-2-mma nd Bcl-x(L) can 
rescue petites from the mitochondria-independent S1 s ate (Fig. 
3). A membrane anchor is not essential for rescue through SI. 
However, rescue from the $2 state needs a membrane anchor 
domain probably because membrane association of Bcl-2-1ike 
proteins is indispensable for overcoming the effects of Bax in 
the presence of functional mitochondria. The observation that 
Bcl-x(L) can rescue grande cells in minimal and rich medium 
(in contrast o mBcl-2-mma which rescues grandes only in rich 
medium) may imply that small amounts of Bcl-x(L), which are 
expressed in minimal SD medium, are enough to abrogate the 
deleterious effects of Bax. Protein expression in SD is known 
to be poor compared to the amounts produced in rich medium 
[31]. It is possible that Bcl-x(L) has a much stronger affinity for 
Bax than Bcl-2. The mechanism by which homodimeric Bax is 
physically inactivated is believed to occur through formation 
of Bax-Bcl-2 and Bax-Bcl-x(L) heterodimers [4,8]. It is likely 
that the amounts of Bcl-x(L) produced in SD, even with the 
weakly constitutive C YPI  promoter, are sufficient to nullify the 
Bax-induced phenotype in grande yeast (i.e. from $2) but not 
in the petite (i.e. from S1). 
The importance of mitochondria in apoptosis is not clearly 
understood. There have been contradictory findings about its 
function in apoptosis [32,33]. Unlike multicellular organisms, 
the yeast S. cerevisiae has the unique ability to survive without 
functional mitochondria nd to live by glycolysis alone. Al- 
though the classical manifestations of apoptotic ell death (viz. 
DNA fragmentation) [14] may not be apparent in yeast (W.G. 
and B.C., unpublished data), we feel that the simple eukaryote 
S. cerevisiae could still be used as an organism to elucidate the 
true role of mitochondria in apoptosis and inhibition of apop- 
tosis. 
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